Mechanistically, scRNA‐seq analysis revealed upregulation of the chemo‐resistance‐related MYC‐Notch‐non‐NE axis and a more immune‐responsive tumor microenvironment in peripheral ES‐SCLC. Here, MYC is linked to neoplasm.